Previous close | 4.0300 |
Open | 4.1200 |
Bid | 4.0900 x 1000 |
Ask | 4.1200 x 1200 |
Day's range | 4.0300 - 4.1750 |
52-week range | 3.6200 - 8.0500 |
Volume | |
Avg. volume | 1,384,858 |
Market cap | 1.208B |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.5100 |
Earnings date | 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 15.38 |
Quite a few insiders have dramatically grown their holdings in AbCellera Biologics Inc. ( NASDAQ:ABCL ) over the past...
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VANCOUVER, British Columbia, May 01, 2024--AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies